[结直肠癌中的瘤免疫细胞相互作用和衰老相关分子]
1Institut für Pathologie, Universitätsmedizin Mainz, Mainz, Deutschland. franziska.kellers@uksh.de.
Pathologie (Heidelberg, Germany)
|December 1, 2023
概括
细胞衰老标记在结直肠癌 (CRC) 中显示出预后价值. 衰老的瘤细胞和CD8+免疫细胞的接近表明更好的预后,突出瘤微环境在抗瘤免疫中的作用.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
背景情况:
- 细胞衰老是一种稳定的细胞循环停止,防止前恶性细胞增殖.
- 衰老会引发表型,代谢和微环境的变化,影响瘤免疫监测,并可能促进恶性瘤.
- 了解衰老的双重作用对于癌症进展和治疗策略至关重要.
研究的目的:
- 评估结直肠癌 (CRC) 中衰老标志物的预后意义.
- 为了阐明瘤微环境中的衰老瘤细胞和免疫细胞之间的相互作用.
主要方法:
- 免疫组织化学和数字图像分析来自598名CRC患者的组织微阵列.
- 衰老标记与疾病特异性存活率 (DSS) 和无进展存活率 (PFS) 的相关性.
- 在CRC细胞系中体外诱导衰老和与免疫细胞共同培养实验以研究相互作用.
主要成果:
- 衰老标记表达水平与不同的DSS和PFS结果相关.
- 在p21+衰老瘤细胞和CD8+免疫细胞的接近之间观察到显著的正相关性,并改善了DSS和PFS.
- 实验室研究表明,免疫细胞通过直接接触和亡诱导对衰老细胞进行剂量依赖的消除.
结论:
- 衰老标记在CRC中具有显著的预后相关性,反映了抗瘤机制的启动.
- 细胞衰老的效应是类的,并且高度依赖于瘤微环境和免疫监测.
- 对衰老细胞和瘤透免疫细胞的近距离分析提供了关键的预后信息,强调了它们的相互作用的重要性.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K


